Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
healthcatalystcapital.com

See what CB Insights has to offer

Investments

22

Portfolio Exits

2

Funds

2

About Health Catalyst Capital Management

Health Catalyst Capital Management is an independent private equity fund investing in growth-stage healthcare technology and technology-enabled services businesses that seek to improve the human condition and promote value-based care. Current and former investments include Cardiogram, PierianDx, Medal, Risalto, HealthMine, ReferWell, InsightIn, Artimis, 1DocWay, Board Vitals, Clareto and others.

Health Catalyst Capital Management Headquarter Location

515 Madison Avenue

New York, New York, 10022,

United States

212-752-2225

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Health Catalyst Capital Management Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Health Catalyst Capital Management Rank

Latest Health Catalyst Capital Management News

Risalto Health collects another $7M for its MSK concierge platform

Nov 14, 2019

After fueling its seed round last year, Health Catalyst Capital Management again lead the startup's funding. Share Musculoskeletal digital health platform Risalto Health bagged $7 million in new funding from Health Catalyst Capital Management, the startup announced yesterday. WHAT THEY DO The New York-based company use artificial intelligence to find muscular and skeletal health providers in the user’s area. Patients navigate these selections through the company’s app, which acts as a digital concierge that helps select prompt, appropriate care for their condition. Risalto aims to partner with payers and providers alike to streamline patients’ access to care. According to the company, the platform has been shown to reduce patients’ pain scores by as much as 50%, and influences members’ care choices at a 95% success rate. Alongside Health Catalyst Capital Management, the company boasts Oxeon Venture Studio as an institutional investor. WHAT IT’S FOR In addition to funding improvements to the platform itself, Risalto said that these new dollars will help scale the digital musculoskeletal program across the nation. "Each day we spend working with patients it becomes more apparent that there is a lack of coordination and vital resources for those with MSK issues," Dr. Daniel Pizzarello, founder and CEO of Risalto, said in a statement. "We're excited to continue our partnership with HCCM to scale nationwide and help ensure that every patient gets the care that they deserve so that they can avoid dangerous drugs and unnecessary surgeries.” MARKET SNAPSHOT Yesterday’s announcement comes nearly a year and a half after Risalto’s $1.5 million seed round , which was also headed by Health Catalyst Capital Management. That same year saw fundings for similar concierge services addressing different areas of care, such as SteadyMD ( $2.5 million in March 2018 ) and Accolade ( $50 million in April 2018 ). Further, it was only two months ago that Firefly announced its $10.2 million Series A round , and the appointment of athenahealth’s former firebrand Jonathan Bush as its executive chairman. ON THE RECORD "Health Catalyst Capital has focused on MSK as a major pain point in the healthcare system. By investing a second time in Risalto Health as it transforms MSK care, Health Catalyst Capital is furthering its mission of improving healthcare system access and quality while lowering costs," Charles Boorady, founding managing director at Health Catalyst Capital Management, said in a statement. “We have been very impressed by the progress made by Dan and the team at Risalto since our last investment. We are excited now to support their scale-up and roll-out to employers and health plans nationally. "  Tags:

Health Catalyst Capital Management Investments

22 Investments

Health Catalyst Capital Management has made 22 investments. Their latest investment was in Holmusk as part of their Series B on December 12, 2021.

CBI Logo

Health Catalyst Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/6/2021

Series B

Holmusk

No

1

11/2/2021

Series B - II

PierianDx

$30M

No

11

10/22/2021

Series B

Click Therapeutics

$52M

Yes

15

9/9/2021

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

6/21/2021

Series C

Subscribe to see more

Subscribe to see more

10

Date

12/6/2021

11/2/2021

10/22/2021

9/9/2021

6/21/2021

Round

Series B

Series B - II

Series B

Unattributed VC - II

Series C

Company

Holmusk

PierianDx

Click Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$30M

$52M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

11

15

10

10

Health Catalyst Capital Management Portfolio Exits

2 Portfolio Exits

Health Catalyst Capital Management has 2 portfolio exits. Their latest portfolio exit was Clareto on April 12, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/12/2022

Acquired

1

6/18/2018

Acquired

Subscribe to see more

Subscribe to see more

10

Date

4/12/2022

6/18/2018

Exit

Acquired

Acquired

Companies

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Sources

1

10

Health Catalyst Capital Management Fund History

2 Fund Histories

Health Catalyst Capital Management has 2 funds, including Health Catalyst Capital II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/1/2020

Health Catalyst Capital II

Multi-Stage Venture Capital

Open

$50.75M

3

12/28/2016

Health Catalyst Capital

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/1/2020

12/28/2016

Fund

Health Catalyst Capital II

Health Catalyst Capital

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$50.75M

$99M

Sources

3

10

Health Catalyst Capital Management Team

1 Team Member

Health Catalyst Capital Management has 1 team member, including current Managing Partner, Charles Boorady.

Name

Work History

Title

Status

Charles Boorady

Managing Partner

Current

Name

Charles Boorady

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.